Thomas G. Wiggans, CEO & Chairman of the Board at Dermira, Inc. (DERM), sold 500 shares at $27.58 ($14K) on 2017-08-01, disclosed to the SEC on 2017-08-02.
Scheduled sale ($14k) by CEO & Chairman of the Board under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| JSPR | BUY | 2023-11-22 | $6K | — | Filing → |
| JSPR | BUY | 2023-11-20 | $18K | — | Filing → |
| PRDS | BUY | 2022-12-07 | $14K | — | Filing → |